GATA3 and breast cancer: Although 29% (5 out of 17) of p18mt;Gata3+/- mammary tumors and none (0 out of 8) of p18mt mammary tumors metastasized to lung, no significant increase of metastasis was observed in p18mt;Gata3+/- tumors relative to p18mt tumors when statistical analysis was conducted.